Molnupiravir COVID-19 Medicine: Merck’s COVID-19 drug shows 50% efficacy in reducing hospitalization and deaths - Job Community

Tuesday, 5 October 2021

Home Current Affairs Jagran Josh Molnupiravir COVID-19 Medicine: Merck’s COVID-19 drug shows 50% efficacy in reducing hospitalization and deaths

Molnupiravir COVID-19 Medicine: Merck’s COVID-19 drug shows 50% efficacy in reducing hospitalization and deaths

Md Wasim Abbas 01:52 Current Affairs, Jagran Josh,

Merck and Ridgeback Biotherapeutics announced its new anti-viral drug Molnupiravir to treat COVID-19 infection. All you need to know

from Jagran Josh https://ift.tt/3mtODRh

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Created By Wasim Abbas | Distributed By Job Community